Alexander Rudensky

Howard Hughes Medical Institute Investigator; Chairman, Immunology Program, Sloan-Kettering Institute; Director, Ludwig Center for Cancer Immunotherapy; Tri-Institutional Professor, Memorial Sloan-Kettering Cancer Center, the Rockefeller University, and Cornell University; Co-Founder & Scientific Advisory Board Member, Vedanta Biosciences

Dr. Rudensky is an internationally-recognized leader in the field of immune regulation, where he has made numerous seminal discoveries including the identification of the molecular mechanisms of regulatory T cell differentiation. Dr. Rudensky was elected to the National Academy of Sciences in 2012.